A carregar...

Concise Drug Review: Azacitidine and Decitabine

The introduction of the hypomethylating agents azacitidine and decitabine has been a major advancement in the treatment of patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia who are ineligible for more intensive treatments. This concise d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Derissen, Ellen J.B., Beijnen, Jos H., Schellens, Jan H.M.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662854/
https://ncbi.nlm.nih.gov/pubmed/23671007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!